1. A higher dietary intake of phenolic acids is protective against insulin resistance and non-alcoholic fatty liver disease. (February 2020) Authors: Salomone, F.; Ivancovsky-Wajcman, D.; Grosso, G.; Galvano, F.; Kariv, R.; Zelber-Sagi, S. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of HCV eradication by DAA on oxidative stress parameters in patients with chronic hepatitis C. (February 2019) Authors: Salomone, F.; Petta, S.; Distefano, A.; Calvaruso, V.; Castracane, C.C.; Grimaudo, S.; Pipitone, R.; Rini, F.; Galvano, F.; Di Marco, V.; Craxì, A.; Volti, G. Li Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. HCV eradication by DAA improves glucose tolerance and reduces post-load insulin resistance in cirrhotic patients with genotype 1. Issue 1 (February 2018) Authors: Salomone, F.; Catania, M.; Bertino, G.; Godos, J.; Magrì, G.; Li Volti, G.; Montineri, A. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Liver damage can be associated with deregulation of the de novo lipogenesis pathway in subjects with Non Alcoholic Fatty Liver Disease. (15th February 2015) Authors: Rosso, C.; Saponaro, C.; Mezzabotta, L.; Vanni, E.; Gambino, R.; Saba, F.; Jouness, R. Ibrahim Kamal; Gaggini, M.; Buzzigoli, E.; Caviglia, G.P.; Abate, M.L.; Salomone, F.; Smedile, A.; Rizzetto, M.; Cassader, M.; Gastaldelli, A.; Bugianesi, E. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Protective role of soluble receptor of advanced glycation end-products in non-alcoholic fatty liver disease. (7th October 2015) Authors: Salomone, F.; Morello, E.; Parola, M.; Zelber-Sagi, S. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 3 Page Start: e234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Silibinin exerts beneficial effects in experimental and human non-alcoholic steatohepatitis. (7th October 2015) Authors: Salomone, F.; Godos, J.; Catania, M.; Magrì, G.; Galvano, F. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 3 Page Start: e234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SIRT5 rs12216101 T>G variant is associated with fibrosis severity in patients with non-alcoholic fatty liver disease. (March 2021) Authors: Salomone, F.; Grimaudo, S.; Malvestiti, F.; Pipitone, R.M.; Distefano, A.; Baselli, G.; Pennisi, G.; Dongiovanni, P.; Fracanzani, A.L.; Li Volti, G.; Craxì, A.; Romeo, S.; Valenti, L.; Petta, S. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SIRT5 rs12216101 T>G variant is associated with oxidative stress and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease. (March 2023) Authors: Salomone, F.; Pipitone, R.M.; Longo, M.; Malvestiti, F.; Casirati, E.; Distefano, A.; Amorini, M.; Volti, G. Li; Ciociola, E.; Lazzarino, G.; Craxì, A.; Fracanzani, A.L.; Dongiovanni, P.; Valenti, L.; Petta, S.; Grimaudo, S. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗